CEO, Justin Chen, JD/MS
Mr. Chen is the co-founder of Starvax Inc. and has served as its CEO since its inception. Prior to that, he is the founder and managing director of PacGate Law Group, a silicon valley based law firm with a primary focus on providing legal services relating to cross-border business transactions between the US and China. Prior to this, Mr. Chen was a partner at Intellectual Property Law Group LLP, a silicon valley based law firm specializing in Intellectual property and trademark. Mr. Chen has also served on the board of many not-for-profit organizations, such as the Hua Yuan Science and Technology Association, Peking University Alumni Association.

President/CSO, Yiyou Chen, Ph.D.
Dr. Chen is the co-founder of Starvax Inc., and is responsible for the overall scientific direction of the company. Before founding Starvax Inc., Dr. Chen was a senior scientist at Genencor International Inc., a large US biotech company with over 380 million dollar revenue each year. He has conducted research on a variety of projects, including immunotherapeutics, protein engineering, and transgenic mouse model. Dr. Chen has served as a co-project leader for the immunotherapeutic program covering HBV and HPV. The program was later sold to Innogenics for 90 million US dollars. Prior to joining Genencor, Dr. Chen was a postdoctoral fellow at University of Utah Department of Pathology, conducting research on the functions of Pactolus, a gene he discovered in 1997.

CBO, Y. Alex Wu, Ph.D., MBA
Dr. Wu was most recently an Associate at Burrill & Company, one of the world's premium life sciences merchant banks with over $500 million under management for venture capital investments, responsible for the company's business activities in Asia, including strategy formulation, fund raising, venture capital investments, and strategic partnering. Prior to that, He worked for Hoffmann-La Roche, a Swiss pharmaceutical company, as Manager of Business Development and Strategic Planning. He was involved in product in-licensing, co-development and co-promotion, and to a lesser degree, product out-licensing with experience in analyzing, negotiating and executing strategic alliances and joint-ventures. He also participated in formulating Roche's 5-year strategic plan. As an entrepreneur, he was involved in a series of start-ups, one of which was Unimicro Technologies, Inc., a bio-analytical instrumentation company in California. As its Chief Operating Officer, Alex was in charge of the company's overall business strategy and daily operations, including fund-raising, marketing and sales, business development and finance. He also helped to establish a joint-venture in Shanghai, China.

VP of Operation, Felix Lin
Mr. Lin was most recently Director of International Marketing at Daan Gene Ltd of Sun Yet-San University, a public-listed biotech company in China. He was in charge of international filing and marketing of the company's products. Prior to that, Mr. Lin was the General Manager at Shenzhen Inkelong Electronics Corporation, a manufacturer of consumer electronic products. He was responsible for overseeing company's daily operation as well as outside relationship with vendors and customers. Mr. Lin has a Bachelor's degree in biochemistry for Peking University in 1992.